Hanmi Science Co., Ltd. (008930) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hanmi Science Co., Ltd. (008930:KRX), powered by AI.

Current Price
₩38,550
P/E Ratio
43.9
Market Cap
2.6T
Sector
Healthcare
What is the Hanmi Science Co., Ltd. stock price forecast?

Hanmi Science Co., Ltd. is currently trading at ₩38,550. View real-time AI analysis on Alpha Lenz.

What is Hanmi Science Co., Ltd. insider trading activity?

View the latest insider trading data for Hanmi Science Co., Ltd. on Alpha Lenz.

What is Hanmi Science Co., Ltd.'s P/E ratio?

Hanmi Science Co., Ltd.'s P/E ratio is 43.9.

Hanmi Science Co., Ltd.

KRX · 008930
₩38,550
Ask about Hanmi Science Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Hanmi Science Co., Ltd. trades at a P/E of 43.9 (premium valuation) with modest ROE of 7.3%. 3Y revenue CAGR of 10.5% highlights clear growth momentum.

Ask for details

Company Overview

Hanmi Science Co., Ltd. is a prominent South Korean company engaged in the pharmaceutical and biotechnology sectors, with a focus on developing innovative healthcare solutions. As the holding company of Hanmi Pharmaceuticals, its primary function is to drive drug discovery and ensure the availability of effective medical products. Hanmi Science undertakes research and development activities, emphasizing biopharmaceuticals and chemical drugs, particularly in areas like oncology, diabetes, and autoimmune diseases. The company plays a vital role in the healthcare industry by advancing medical research and contributing to improving public health outcomes. Operating as a key player within the biotechnology market, Hanmi Science influences the proliferation of cutting-edge therapies and medicines, both in South Korea and internationally. Its commitment to innovation and therapeutic advancements has positioned it as a critical contributor to the global pharmaceuticals landscape, impacting not only direct healthcare provision but also broader industry research collaborations and partnerships.

CEO김재교
SectorHealthcare
IndustryMedical Distribution
Employees443

Company Statistics

FY 2024

Profile

₩2,636,494,252,500Market Cap
₩1,283,432,295,640Revenue
68.39MShares Out
443Employees

Margins

21.24%Gross
8.23%EBITDA
2.96%Operating
4.92%Pre-Tax
4.42%Net

Valuation

43.93P/E
3.10P/B
2.03EV/Sales
25.93EV/EBITDA
36.59P/FCF

Growth (CAGR)

10.54%Rev 3Yr
9.46%Rev 5Yr
9.70%Op Inc 3Yr
18.65%Op Inc 5Yr
9.70%Net Inc 3Yr
13.02%Net Inc 5Yr

Returns

4.40%ROA
7.30%ROE
5.78%ROIC

Financial Health

₩85,228,453,220Cash & Cash Equivalents
₩425,146,766,860Net Debt
60.85%Debt/Equity
8.02Interest Cov

Frequently Asked Questions

Hanmi Science Co., Ltd. (ticker: 008930) is a company listed on KRX in the Healthcare sector (Medical Distribution). It has approximately 443 employees. Market cap is $2.6T.

The current price is ₩38,550 with a P/E ratio of 43.93x and P/B of 3.1x.

ROE is 7.30% and operating margin is 2.96%. Annual revenue is $1.3T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Hanmi Science Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩38,550 | Alpha Lenz